Journal of Surgical Oncology 2024 July 31 [Link]
Xin-Li Liang, Xin-Bao Li, Yu-Bin Fu, Yan-Dong Su, Ru Ma, Rui Yang, He-Liang Wu, Yan Li
Abstract
Malignant peritoneal mesothelioma (MPM) is a rare and invasive tumor, and some patients will develop paraneoplastic syndrome (PS) during the course of the disease. This review summarizes PS associated with MPM, focusing on the clinical characteristics and treatment progress in hematological, endocrine, rheumatic, neurological, urinary, and other systems to decrease missed diagnosis and misdiagnosis, help early diagnosis and prompt treatment, and provide guidance for the clinical decision-making of this kind of patients.
The post Research progress of malignant peritoneal mesothelioma with paraneoplastic syndrome: A review appeared first on Mesothelioma Line.
The post Research progress of malignant peritoneal mesothelioma with paraneoplastic syndrome: A review appeared first on Mesothelioma Line.
